Condition
Exercise-induced Asthma
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02410096Not ApplicableCompletedPrimary
Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation
NCT02026492Not ApplicableCompletedPrimary
Exercise Challenge in a Cold Chamber
NCT00322283Phase 2CompletedPrimary
Study of Oglemilast for the Prevention of Asthma.
NCT00935415Phase 4CompletedPrimary
Time-Effect of Montelukast Protection
Showing all 4 trials